PRA Health Sciences’ Early Development Services (EDS) team of dedicated experts understands that obtaining patient safety and efficacy data early in the clinical pharmacology program plays a critical role in decision-making and lays the groundwork for efficient future development planning.
Explore related content and topics
Page
Healthy Volunteers
Phase I healthy volunteer studies play a vital role in clinical research by providing researchers with the knowledge they need to make educated…
Read More
Page
Human Abuse Potential and Liability (HAP)
We’ve successfully completed more Human Abuse Potential and Liability (HAP/HAL) protocols & published more HAP studies than any other CRO.
Read More
Capability
Renal Impairment Studies — Early Patient Solutions
PRA Health Sciences’ Early Development Services (EDS) has established a team dedicated to early phase patient studies. Our Early Patient Solutions…
View Resource
View all related content and resources for Early Phase Solutions
Explore Insights